These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 19307114

  • 1. A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties.
    Moss N, Choi Y, Cogan D, Flegg A, Kahrs A, Loke P, Meyn O, Nagaraja R, Napier S, Parker A, Thomas Peterson J, Ramsden P, Sarko C, Skow D, Tomlinson J, Tye H, Whitaker M.
    Bioorg Med Chem Lett; 2009 Apr 15; 19(8):2206-10. PubMed ID: 19307114
    [Abstract] [Full Text] [Related]

  • 2. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
    Haydar SN, Yun H, Andrae PM, Mattes J, Zhang J, Kramer A, Smith DL, Huselton C, Graf R, Aschmies S, Schechter LE, Comery TA, Robichaud AJ.
    J Med Chem; 2010 Mar 25; 53(6):2521-7. PubMed ID: 20170099
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.
    Kelly CR, Sharif NA.
    J Pharmacol Exp Ther; 2006 Jun 25; 317(3):1254-61. PubMed ID: 16517693
    [Abstract] [Full Text] [Related]

  • 4. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
    Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, Asaka M.
    Gastroenterology; 2008 Jun 25; 134(7):2004-13. PubMed ID: 18439428
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 5-HT2B receptors do not modulate sensitivity to colonic distension in rats with acute colorectal hypersensitivity.
    Greenwood-Van Meerveld B, Campbell-Dittmeyer K, Johnson AC, Hicks GA.
    Neurogastroenterol Motil; 2006 May 25; 18(5):343-5. PubMed ID: 16629860
    [Abstract] [Full Text] [Related]

  • 10. A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonists.
    Goodacre CJ, Bromidge SM, Clapham D, King FD, Lovell PJ, Allen M, Campbell LP, Holland V, Riley GJ, Starr KR, Trail BK, Wood MD.
    Bioorg Med Chem Lett; 2005 Nov 15; 15(22):4989-93. PubMed ID: 16168649
    [Abstract] [Full Text] [Related]

  • 11. Emerging opportunities and concerns for drug discovery at serotonin 5-HT2B receptors.
    Brea J, Castro-Palomino J, Yeste S, Cubero E, Párraga A, Domínguez E, Loza MI.
    Curr Top Med Chem; 2010 Nov 15; 10(5):493-503. PubMed ID: 20166944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT₆ receptor antagonists.
    Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK.
    Bioorg Med Chem Lett; 2012 Nov 15; 22(22):6980-5. PubMed ID: 23036955
    [Abstract] [Full Text] [Related]

  • 14. Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.
    Andrews MD, Green MP, Allerton CM, Batchelor DV, Blagg J, Brown AD, Gordon DW, McMurray G, Millns DJ, Nichols CL, Watson L.
    Bioorg Med Chem Lett; 2009 Sep 15; 19(18):5346-50. PubMed ID: 19692241
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor.
    Markowitz JS, DeVane CL, Ramamoorthy S, Zhu HJ.
    Pharmazie; 2009 Feb 15; 64(2):123-5. PubMed ID: 19322953
    [Abstract] [Full Text] [Related]

  • 20. Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.
    Brennan PE, Whitlock GA, Ho DK, Conlon K, McMurray G.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):4999-5003. PubMed ID: 19646865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.